480 related articles for article (PubMed ID: 35530281)
1. Investigation of the effects of overexpression of jumping translocation breakpoint (JTB) protein in MCF7 cells for potential use as a biomarker in breast cancer.
Jayathirtha M; Neagu AN; Whitham D; Alwine S; Darie CC
Am J Cancer Res; 2022; 12(4):1784-1823. PubMed ID: 35530281
[TBL] [Abstract][Full Text] [Related]
2. Investigating the Function of Human Jumping Translocation Breakpoint Protein (hJTB) and Its Interacting Partners through In-Solution Proteomics of MCF7 Cells.
Jayathirtha M; Whitham D; Alwine S; Donnelly M; Neagu AN; Darie CC
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500393
[TBL] [Abstract][Full Text] [Related]
3. Two-Dimensional Polyacrylamide Gel Electrophoresis Coupled with Nanoliquid Chromatography-Tandem Mass Spectrometry-Based Identification of Differentially Expressed Proteins and Tumorigenic Pathways in the MCF7 Breast Cancer Cell Line Transfected for Jumping Translocation Breakpoint Protein Overexpression.
Jayathirtha M; Jayaweera T; Whitham D; Petre BA; Neagu AN; Darie CC
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834160
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the effects of downregulation of jumping translocation breakpoint (JTB) protein expression in MCF7 cells for potential use as a biomarker in breast cancer.
Jayathirtha M; Neagu AN; Whitham D; Alwine S; Darie CC
Am J Cancer Res; 2022; 12(9):4373-4398. PubMed ID: 36225631
[TBL] [Abstract][Full Text] [Related]
5. Two-Dimensional-PAGE Coupled with nLC-MS/MS-Based Identification of Differentially Expressed Proteins and Tumorigenic Pathways in MCF7 Breast Cancer Cells Transfected for JTB Protein Silencing.
Jayathirtha M; Jayaweera T; Whitham D; Sullivan I; Petre BA; Darie CC; Neagu AN
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005222
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Jumping translocation breakpoint (JTB) gene product isolated as a TGF-beta1-inducible clone involved in regulation of mitochondrial function, cell growth and cell death.
Kanome T; Itoh N; Ishikawa F; Mori K; Kim-Kaneyama JR; Nose K; Shibanuma M
Oncogene; 2007 Sep; 26(41):5991-6001. PubMed ID: 17369841
[TBL] [Abstract][Full Text] [Related]
7. HBsAg inhibits the translocation of JTB into mitochondria in HepG2 cells and potentially plays a role in HCC progression.
Liu YP; Yang XN; Jazag A; Pan JS; Hu TH; Liu JJ; Guleng B; Ren JL
PLoS One; 2012; 7(5):e36914. PubMed ID: 22615844
[TBL] [Abstract][Full Text] [Related]
8. JTB: a novel membrane protein gene at 1q21 rearranged in a jumping translocation.
Hatakeyama S; Osawa M; Omine M; Ishikawa F
Oncogene; 1999 Mar; 18(12):2085-90. PubMed ID: 10321732
[TBL] [Abstract][Full Text] [Related]
9. The structure of the extracellular domain of the jumping translocation breakpoint protein reveals a variation of the midkine fold.
Rousseau F; Pan B; Fairbrother WJ; Bazan JF; Lingel A
J Mol Biol; 2012 Jan; 415(1):22-8. PubMed ID: 22079049
[TBL] [Abstract][Full Text] [Related]
10. Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.
Leung D; Price ZK; Lokman NA; Wang W; Goonetilleke L; Kadife E; Oehler MK; Ricciardelli C; Kannourakis G; Ahmed N
J Transl Med; 2022 Dec; 20(1):556. PubMed ID: 36463238
[TBL] [Abstract][Full Text] [Related]
11. Proteomic Analysis of Epithelial to Mesenchymal Transition (EMT) Reveals Cross-talk between SNAIL and HDAC1 Proteins in Breast Cancer Cells.
Palma Cde S; Grassi ML; Thomé CH; Ferreira GA; Albuquerque D; Pinto MT; Ferreira Melo FU; Kashima S; Covas DT; Pitteri SJ; Faça VM
Mol Cell Proteomics; 2016 Mar; 15(3):906-17. PubMed ID: 26764010
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the molecular changes associated with the overexpression of a novel epithelial cadherin splice variant mRNA in a breast cancer model using proteomics and bioinformatics approaches: identification of changes in cell metabolism and an increased expression of lactate dehydrogenase B.
Rosso M; Lapyckyj L; Besso MJ; Monge M; Reventós J; Canals F; Quevedo Cuenca JO; Matos ML; Vazquez-Levin MH
Cancer Metab; 2019; 7():5. PubMed ID: 31086659
[TBL] [Abstract][Full Text] [Related]
13. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
[TBL] [Abstract][Full Text] [Related]
14. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
15. The Translational Controlled Tumour Protein TCTP: Biological Functions and Regulation.
Bommer UA
Results Probl Cell Differ; 2017; 64():69-126. PubMed ID: 29149404
[TBL] [Abstract][Full Text] [Related]
16. Desmocollin-1 is associated with pro-metastatic phenotype of luminal A breast cancer cells and is modulated by parthenolide.
Lapcik P; Sulc P; Janacova L; Jilkova K; Potesil D; Bouchalova P; Müller P; Bouchal P
Cell Mol Biol Lett; 2023 Aug; 28(1):68. PubMed ID: 37620794
[TBL] [Abstract][Full Text] [Related]
17. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer cell secretome analysis to decipher miRNA regulating the tumor microenvironment and discover potential biomarkers.
Feser R; Opperman RM; Nault B; Maiti S; Chen VC; Majumder M
Heliyon; 2023 Apr; 9(4):e15421. PubMed ID: 37128318
[TBL] [Abstract][Full Text] [Related]
19. Interacting with HBsAg compromises resistance of jumping translocation breakpoint protein to ultraviolet radiation-induced apoptosis in 293FT cells.
Pan JS; Cai JY; Xie CX; Zhou F; Zhang ZP; Dong J; Xu HZ; Shi HX; Ren JL
Cancer Lett; 2009 Nov; 285(2):151-6. PubMed ID: 19487072
[TBL] [Abstract][Full Text] [Related]
20. 17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration.
Aka JA; Zerradi M; Houle F; Huot J; Lin SX
Breast Cancer Res; 2012 Jun; 14(3):R92. PubMed ID: 22691413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
